Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Efficacy of inactivated trivalent influenza vaccine in rural India: a 3-year cluster-randomised controlled trial.

Sullender WM, Fowler KB, Gupta V, Krishnan A, Ram Purakayastha D, Srungaram Vln R, Lafond KE, Saha S, Palomeque FS, Gargiullo P, Jain S, Lal R, Widdowson MA, Broor S.

Lancet Glob Health. 2019 Jul;7(7):e940-e950. doi: 10.1016/S2214-109X(19)30079-8.

2.

Co-Circulation of 72bp Duplication Group A and 60bp Duplication Group B Respiratory Syncytial Virus (RSV) Strains in Riyadh, Saudi Arabia during 2014.

Ahmed A, Haider SH, Parveen S, Arshad M, Alsenaidy HA, Baaboud AO, Mobaireek KF, AlSaadi MM, Alsenaidy AM, Sullender W.

PLoS One. 2016 Nov 11;11(11):e0166145. doi: 10.1371/journal.pone.0166145. eCollection 2016.

3.
4.

Retrospective phylogenetic analysis of circulating BA genotype of human respiratory syncytial virus with 60 bp duplication from New Delhi, India during 2007-2010.

Raghuram S V, Khan WH, Deeba F, Sullender W, Broor S, Parveen S.

Virusdisease. 2015 Dec;26(4):276-281. doi: 10.1007/s13337-015-0283-7. Epub 2015 Nov 2.

5.

Matrix Metalloproteinase-9 Mediates RSV Infection in Vitro and in Vivo.

Kong MY, Whitley RJ, Peng N, Oster R, Schoeb TR, Sullender W, Ambalavanan N, Clancy JP, Gaggar A, Blalock JE.

Viruses. 2015 Jul 30;7(8):4230-53. doi: 10.3390/v7082817. Erratum in: Viruses. 2015 Oct;7(10):5609.

6.

Clinical differences between influenza A (H1N1) pdm09 & influenza B infections identified through active community surveillance in North India.

Purakayastha DR, Gupta V, Broor S, Sullender W, Fowler K, Widdowson MA, Lal RB, Krishnan A.

Indian J Med Res. 2013 Dec;138(6):962-8.

7.

Pulmonary matrix metalloproteinase-9 activity in mechanically ventilated children with respiratory syncytial virus.

Kong MY, Clancy JP, Peng N, Li Y, Szul TJ, Xu X, Oster R, Sullender W, Ambalavanan N, Blalock JE, Gaggar A.

Eur Respir J. 2014 Apr;43(4):1086-96. doi: 10.1183/09031936.00105613. Epub 2013 Dec 5.

8.

Incidence of symptomatic A(H1N1)pdm09 influenza during the pandemic and post-pandemic periods in a rural Indian community.

Fowler KB, Gupta V, Sullender W, Broor S, Widdowson MA, Lal RB, Krishnan A.

Int J Infect Dis. 2013 Dec;17(12):e1182-5. doi: 10.1016/j.ijid.2013.08.005. Epub 2013 Sep 12.

9.

Respiratory syncytial virus infection disrupts monolayer integrity and function in cystic fibrosis airway cells.

Kong M, Maeng P, Hong J, Szczesniak R, Sorscher E, Sullender W, Clancy JP.

Viruses. 2013 Sep 19;5(9):2260-71. doi: 10.3390/v5092260.

10.

Demographic shift of influenza A(H1N1)pdm09 during and after pandemic, rural India.

Broor S, Sullender W, Fowler K, Gupta V, Widdowson MA, Krishnan A, Lal RB.

Emerg Infect Dis. 2012 Sep;18(9):1472-5. doi: 10.3201/eid1809.111847.

11.

Design and initiation of a study to assess the direct and indirect effects of influenza vaccine given to children in rural India.

Sullender W, Fowler K, Krishnan A, Gupta V, Moulton LH, Lafond K, Widdowson MA, Lal RB, Broor S.

Vaccine. 2012 Jul 27;30(35):5235-9. doi: 10.1016/j.vaccine.2012.06.002. Epub 2012 Jun 16.

12.

Genetic diversity of HA1 domain of hemagglutinin gene of pandemic influenza H1N1pdm09 viruses in New Delhi, India.

Mir MA, Lal RB, Sullender W, Singh Y, Garten R, Krishnan A, Broor S.

J Med Virol. 2012 Mar;84(3):386-93. doi: 10.1002/jmv.23205.

PMID:
22246823
13.

Seroepidemiological study of human metapneumovirus in New Delhi, India.

Banerjee S, Sullender WM, Ahuja RK, Broor S.

Indian J Med Microbiol. 2011 Oct-Dec;29(4):363-7. doi: 10.4103/0255-0857.90162.

14.

Detection and genetic diversity of human metapneumovirus in hospitalized children with acute respiratory infections in India.

Banerjee S, Sullender WM, Choudekar A, John C, Tyagi V, Fowler K, Lefkowitz EJ, Broor S.

J Med Virol. 2011 Oct;83(10):1799-810. doi: 10.1002/jmv.22176.

15.

Human bocavirus infection in children with acute respiratory tract infection in India.

Bharaj P, Sullender WM, Kabra SK, Broor S.

J Med Virol. 2010 May;82(5):812-6. doi: 10.1002/jmv.21637.

PMID:
20336746
16.

Respiratory viral infections detected by multiplex PCR among pediatric patients with lower respiratory tract infections seen at an urban hospital in Delhi from 2005 to 2007.

Bharaj P, Sullender WM, Kabra SK, Mani K, Cherian J, Tyagi V, Chahar HS, Kaushik S, Dar L, Broor S.

Virol J. 2009 Jun 26;6:89. doi: 10.1186/1743-422X-6-89.

17.

Respiratory syncytial virus inhibits lung epithelial Na+ channels by up-regulating inducible nitric-oxide synthase.

Song W, Liu G, Bosworth CA, Walker JR, Megaw GA, Lazrak A, Abraham E, Sullender WM, Matalon S.

J Biol Chem. 2009 Mar 13;284(11):7294-306. doi: 10.1074/jbc.M806816200. Epub 2009 Jan 8.

18.

Inhibition of Na+ transport in lung epithelial cells by respiratory syncytial virus infection.

Chen L, Song W, Davis IC, Shrestha K, Schwiebert E, Sullender WM, Matalon S.

Am J Respir Cell Mol Biol. 2009 May;40(5):588-600. doi: 10.1165/rcmb.2008-0034OC. Epub 2008 Oct 23.

19.

A prospective three-year cohort study of the epidemiology and virology of acute respiratory infections of children in rural India.

Broor S, Parveen S, Bharaj P, Prasad VS, Srinivasulu KN, Sumanth KM, Kapoor SK, Fowler K, Sullender WM.

PLoS One. 2007 Jun 6;2(6):e491.

20.

Post-infection A77-1726 blocks pathophysiologic sequelae of respiratory syncytial virus infection.

Davis IC, Lazarowski ER, Chen FP, Hickman-Davis JM, Sullender WM, Matalon S.

Am J Respir Cell Mol Biol. 2007 Oct;37(4):379-86. Epub 2007 May 31.

21.

Respiratory syncytial virus induces insensitivity to beta-adrenergic agonists in mouse lung epithelium in vivo.

Davis IC, Xu A, Gao Z, Hickman-Davis JM, Factor P, Sullender WM, Matalon S.

Am J Physiol Lung Cell Mol Physiol. 2007 Aug;293(2):L281-9. Epub 2007 Apr 13.

22.

Human metapneumovirus infections among children with acute respiratory infections seen in a large referral hospital in India.

Banerjee S, Bharaj P, Sullender W, Kabra SK, Broor S.

J Clin Virol. 2007 Jan;38(1):70-2. Epub 2006 Nov 7.

PMID:
17085070
23.

In vitro and in vivo fitness of respiratory syncytial virus monoclonal antibody escape mutants.

Zhao X, Liu E, Chen FP, Sullender WM.

J Virol. 2006 Dec;80(23):11651-7. Epub 2006 Sep 27.

24.

Genetic variability in the G protein gene of group A and B respiratory syncytial viruses from India.

Parveen S, Sullender WM, Fowler K, Lefkowitz EJ, Kapoor SK, Broor S.

J Clin Microbiol. 2006 Sep;44(9):3055-64.

25.

Regulatory challenges: lessons from recent West Nile virus trials in the United States.

Jester PM, Tilden SJ, Li Y, Whitley RJ, Sullender WM.

Contemp Clin Trials. 2006 Jun;27(3):254-9. Epub 2006 Apr 17.

PMID:
16603417
26.

Genetic diversity among respiratory syncytial viruses that have caused repeated infections in children from rural India.

Parveen S, Broor S, Kapoor SK, Fowler K, Sullender WM.

J Med Virol. 2006 May;78(5):659-65.

PMID:
16555275
27.

Leflunomide prevents alveolar fluid clearance inhibition by respiratory syncytial virus.

Davis IC, Lazarowski ER, Hickman-Davis JM, Fortenberry JA, Chen FP, Zhao X, Sorscher E, Graves LM, Sullender WM, Matalon S.

Am J Respir Crit Care Med. 2006 Mar 15;173(6):673-82. Epub 2005 Dec 30.

28.

Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease.

Falsey AR, Formica MA, Hennessey PA, Criddle MM, Sullender WM, Walsh EE.

Am J Respir Crit Care Med. 2006 Mar 15;173(6):639-43. Epub 2005 Dec 30.

29.
30.

Variable resistance to palivizumab in cotton rats by respiratory syncytial virus mutants.

Zhao X, Chen FP, Megaw AG, Sullender WM.

J Infect Dis. 2004 Dec 1;190(11):1941-6. Epub 2004 Oct 27.

PMID:
15529258
32.

Pulmonary delivery of respiratory syncytial virus DNA vaccines using macroaggregated albumin particles.

Harcourt JL, Anderson LJ, Sullender W, Tripp RA.

Vaccine. 2004 Jun 2;22(17-18):2248-60.

PMID:
15149784
33.
34.
35.

Nucleotide-mediated inhibition of alveolar fluid clearance in BALB/c mice after respiratory syncytial virus infection.

Davis IC, Sullender WM, Hickman-Davis JM, Lindsey JR, Matalon S.

Am J Physiol Lung Cell Mol Physiol. 2004 Jan;286(1):L112-20. Epub 2003 Aug 29.

36.

Genetic variability among Group A and B respiratory syncytial virus isolates from a large referral hospital in New Delhi, India.

Rajala MS, Sullender WM, Prasad AK, Dar L, Broor S.

J Clin Microbiol. 2003 Jun;41(6):2311-6.

37.

Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America.

Peret TC, Hall CB, Hammond GW, Piedra PA, Storch GA, Sullender WM, Tsou C, Anderson LJ.

J Infect Dis. 2000 Jun;181(6):1891-6. Epub 2000 May 22.

PMID:
10837167
38.

Respiratory syncytial virus genetic and antigenic diversity.

Sullender WM.

Clin Microbiol Rev. 2000 Jan;13(1):1-15, table of contents. Review.

39.

Advances in prevention of respiratory syncytial virus infections.

Prober CG, Sullender WM.

J Pediatr. 1999 Nov;135(5):546-58. Review. No abstract available.

PMID:
10547241
41.
42.

Genetic variability among group A and group B respiratory syncytial viruses in a children's hospital.

Coggins WB, Lefkowitz EJ, Sullender WM.

J Clin Microbiol. 1998 Dec;36(12):3552-7.

43.
44.
45.

Central nervous system infection associated with Bartonella quintana: a report of two cases.

Parrott JH, Dure L, Sullender W, Buraphacheep W, Frye TA, Galliani CA, Marston E, Jones D, Regnery R.

Pediatrics. 1997 Sep;100(3 Pt 1):403-8. No abstract available.

PMID:
9282717
46.
47.
49.
50.

Analysis of respiratory syncytial virus genetic variability with amplified cDNAs.

Sullender WM, Sun L, Anderson LJ.

J Clin Microbiol. 1993 May;31(5):1224-31.

Supplemental Content

Loading ...
Support Center